Congestive heart failure is associated with the rate of bone loss

Journal of Internal Medicine

Volumn 253, Issue 4, 2003, Pages 439-446

  Nishio, Kazuaki ^a,b   Mukae, S ^a   Aoki, S ^a   Itoh, S ^a   Konno, N ^a   Ozawa, K ^a   Satoh, R ^a   Katagiri, T ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Heights Matsugaoka 202 ^*  (Japan)

Author keywords

Congestive heart failure; Gene polymorphisms; Human atrial natriuretic peptide; Loop diuretics; Steoporosis; Vitamin D receptor

Indexed keywords

ALKALINE PHOSPHATASE; ATRIAL NATRIURETIC FACTOR; CALCIUM; FUROSEMIDE; VITAMIN D RECEPTOR;

AGED; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEART LEFT VENTRICLE EJECTION FRACTION; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; OSTEOLYSIS; OSTEOPOROSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGED; ANALYSIS OF VARIANCE; BONE DENSITY; CALCIUM; DENSITOMETRY, X-RAY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, CALCITRIOL; REGRESSION ANALYSIS;

EID: 0037390157     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01130.x     Document Type: Article

References (26)

1. Muchmore JS, Cooper DKC, Ye Y, Schlegel VT, Zuhdi N. Loss of vertebral bone density in heart transplant patients. Transplant Proc 1991; 23: 1184-5.
2. Elizabeth S, Donna M, Keith A, Shonni JS. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997; 103: 197-207.
3. Tokita A, Kelly PJ, Nguyen TV et al. Genetic determinants of type I collagen synthesis and degradation: further evidence of genetic regulation of bone turnover. J Clin Endocrinol Metab 1994; 78: 1461-6.
4. Kelly PJ, Eisman JA, Sambrook PN. Interaction of genetic and environmental influences on peak bone density. Osteoporosis Int 1990; 1: 1-5.
5. Eisman JA, Vitamin D receptor gene alleles and osteoporosis: an affirmative view. J Bone Miner Res 1995; 10: 1289-93.
6. Ferrari SL, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjour JP. Vitamin D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density. Lancet 1995; 345: 423-4.
7. Keen RW, Major PJ, Lanchbury JS, Spector TD. Vitamin D-receptor gene polymorphism and bone loss. Lancet 1995; 345: 990.
8. Uitterlinden AG, Pols HAP, Burger H et al. A large-scale population-based study of the association of vitamin D receptor gene polymorphism with bone mineral density. J Bone Miner Res 1996; 11: 1241-7.
9. Gundberg CM, Wilson PS, Gallop PM, Parfitt AM. Determination of osteocalcin in human serum: results with two kits compared with those by a well-characterized assay. Clin Chem 1987; 31: 1720-3.
10. Nussbaum SR, Zahradnik RJ, Lavigne JR et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987; 33: 1364-7.
11. Seibel MJ, Robin SP, Bilezikian JP. Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 1992; 3: 263-70.
12. Black D, Duncan A, Robin SP. Quantitative analysis of pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high performance liquid chromatography. Anal Biochem 1989; 137: 380-8.
13. Gross C, Eccleshall T, Malloy P, Villa M, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 1996; 11: 1850-5.
14. Holbrook TL, Barrett-Conner E, Wingard DL. Dietary calcium and risk of hip fracture: 14-year prospective population study. Lancet 1988; 338: 1046-9.
15. Diane F, David JH, Walter CW et al. Vitamin D receptor genotype and the risk of bone fractures in women. Epidemiology 1998; 9: 535-9.
16. Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjour JP. Vitamin D receptor gene polymorphisms and the rate of change of lumbar spine bone mineral density in elderly men and women. Lancet 1995; 345: 423-4.
17. Dawson-Hughes B, Harris SS, Fineran S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 1995; 80: 3657-61.
18. Tromp AM, Ooms ME, Popp-Snijders C, Roos JC, Lips P. Predictors of fractures in elderly women. Osteoporosis Int 2000; 11: 134-40.
19. Ooms ME, Lips P, van Lingen A, Valkenburg HA. Determinants of bone mineral density and risk factor for osteoporosis in healthy elderly women. J Bone Miner Res 1993; 8: 669-75.
20. Packer M, Lee WH, Kessler PD. Preservation of glomerular filtration rate in human heart failure by activation of the rennin-angiotensin system. Circulation 1986; 74: 766-74.
21. Wasnich RD, Benfante RJ, Katsuhiko Y, Heilbrun L, Vogel JM. Thiazide effect on the mineral content of bone. N Engl J Med 1983; 309: 344-7.
22. Reid IR, Ames RW, Orr-Walker BJ et al. Hydrochlorothiazide reduced loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 2000; 109: 362-70.
23. Sigurdsson G, Franzson L. Increased bone mineral density in a population-based group of 70-year-old women on thiazide diuretics, independent of parathyroid hormone levels. J Intern Med 2001; 250: 51-6.
24. Rejnmark L, Vestergaaed P, Heickendorff L, Andreasen F, Mosekilde L. Effects of thiazide- loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study. J Intern Med 2001; 250: 144-53.
25. Rejnmark L, Vestergaaed P, Heickendorff L, Andreasen F, Mosekilde L. Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythm of calcitropic hormone and biochemical bone markers in postmenopausal women. Eur J Invest 2001; 31: 764-72.
26. Anderson JV, Donckier J, Payne NN, Beacham J, Slater JD, Bloom SR. Atrial natriuretic peptide: evidence of action as a natriuretic hormone at physiological plasma concentrations in man. Clin Sci Lond 1987; 72: 305-12.